Cybin Inc. Stock OTC Markets
Stocks
CLXP.F
CA23256X1006
Biotechnology & Medical Research
OTC Markets Traded|
End-of-day quote
OTC Markets
2021-09-01
|
5-day change | 1st Jan Change | ||
| 2.630 CAD | -6.07% |
|
+17.41% | +76.51% |
| 08-18 | Helus Pharma Announces Management Changes | CI |
| 08-14 | Cybin Inc. Reports Earnings Results for the First Quarter Ended June 30, 2026 | CI |
| Market Cap | 1.24B 889M 768M 719M 657M 84.78B 1.24B 8.54B 3.33B 42.9B 3.34B 3.27B 142B | P/E 2027 * |
-4.61x | P/E 2028 * | -5.77x |
|---|---|---|---|---|---|
| Enterprise Value | 760M 546M 472M 442M 404M 52.13B 764M 5.25B 2.04B 26.38B 2.05B 2.01B 87.5B | EV / Sales 2027 * |
-
| EV / Sales 2028 * | 60.1x |
| Free-Float |
88.79% | Yield 2027 * |
-
| Yield 2028 * | - |
Last Transcript : Cybin Inc.
| 1 day | -6.07% |
| Manager | Title | Age | Since |
|---|---|---|---|
Paul Glavine
COO | Chief Operating Officer | 37 | 2016-10-12 |
Michael Halstead
CEO | Chief Executive Officer | 53 | 2026-08-02 |
Eric So
CEO | Chief Executive Officer | 51 | 2025-09-01 |
| Director | Title | Age | Since |
|---|---|---|---|
Eric So
CHM | Chairman | 51 | 2020-11-04 |
Paul Glavine
BRD | Director/Board Member | 37 | 2016-10-12 |
Eric Hoskins
BRD | Director/Board Member | 65 | 2020-11-04 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -6.07% | +17.41% | - | - | 890M | |
| -1.59% | -3.35% | +64.49% | +98.69% | 69.54B | |
| -1.34% | -0.75% | +48.21% | +91.86% | 64.97B | |
| -8.37% | -12.43% | +2.08% | -16.71% | 25.64B | |
| -2.35% | -5.75% | -12.90% | +448.54% | 25.89B | |
| +0.30% | -0.69% | +63.18% | +11.93% | 26.51B | |
| -0.96% | +10.36% | +278.86% | +438.78% | 20.22B | |
| -0.51% | +0.23% | +33.71% | -18.02% | 19.98B | |
| -1.91% | -4.37% | +13.33% | +531.29% | 15.69B | |
| -1.47% | +0.68% | +45.51% | +143.08% | 13.49B | |
| Average | -2.43% | -1.93% | +59.61% | +192.16% | 31.33B | |
| Weighted average by Cap. | -1.94% | -1.50% | +57.27% | +152.90% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | - | 11.07M 7.95M 6.87M 6.43M 5.88M 759M 11.12M 76.4M 29.77M 384M 29.89M 29.24M 1.27B |
| Net income | -261M -187M -162M -152M -139M -17.88B -262M -1.8B -701M -9.05B -704M -689M -30.01B | -262M -188M -162M -152M -139M -17.94B -263M -1.81B -704M -9.08B -707M -691M -30.11B |
| Net Debt | -476M -342M -296M -277M -253M -32.65B -479M -3.29B -1.28B -16.52B -1.29B -1.26B -54.8B | -571M -410M -355M -332M -303M -39.16B -574M -3.94B -1.54B -19.81B -1.54B -1.51B -65.72B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- HELP Stock
- CLXP.F Stock
Select your edition
All financial news and data tailored to specific country editions
